This Article Abstract Full Text Full Text (PDF) View Related Interview Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pascual-Figal, D. A. Search for Related Content PubMed PubMed Citation Articles by Pascual-Figal, D. A. Related Collections Related Article

Soluble ST2 for Predicting Sudden Cardiac Death in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction

Domingo A. Pascual-Figal, MD, PhD^_*,_*, Jordi Ordoñez-Llanos, MD, PhD, Pedro L. Tornel, PhD, Rafael Vázquez, MD, PhD^||, Teresa Puig, MD, PhD, Mariano Valdés, MD, PhD^_*, Juan Cinca, MD, PhD, Antoni Bayes de Luna, MD, PhD^¶, Antoni Bayes-Genis, MD, PhD on behalf of the MUSIC Investigators

^_* Cardiology Service, Virgen de la Arrixaca Hospital and Department of Medicine, University of Murcia, Murcia, Spain
Biochemistry Service, Sant Pau Hospital and Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Barcelona, Spain
Cardiology Service, Sant Pau Hospital, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
Biochemistry Service, Virgen de la Arrixaca Hospital, Murcia, Spain
^|| Cardiology Service, Hospital Universitario Puerta del Mar, Cádiz, Spain
^¶ Institut Català de Ciències Cardiovasculars, Barcelona, Spain

View larger version (9K): [in this window] [in a new window] [Download PPT slide]   Figure 1 sST2 and NT-proBNP in Patients With SCD and Survivors Box plots showing the baseline concentrations of soluble ST2 (sST2) (A) and N-terminal pro–B-type natriuretic peptide (NT-proBNP) (B) in patients experiencing sudden cardiac death (SCD) and the control survivor group.

View larger version (18K): [in this window] [in a new window] [Download PPT slide]   Figure 2 Receiver-Operator Characteristic Curve Analysis of sST2 and NT-proBNP Concentrations for Predicting SCD AUC = area under the curve; other abbreviations as in Figure 1.

View larger version (15K): [in this window] [in a new window] [Download PPT slide]   Figure 3 Events According to the Presence of None, Either, or Both sST2 >0.15 ng/ml and NT-proBNP >2,000 ng/l Red bars = sudden cardiac death; open bars = survivors. Abbreviations as in Figure 1.